Yüklüyor......
Targeting of histone deacetylases in brain tumors
Histone deacetylase inhibitors (HDACis) have fascinated researchers in almost all fields of oncology for many years owing to their pleiotropic effects on nearly every aspect of cancer biology. Since the approval of the first HDACi vorinostat for the treatment of cutaneous T-cell leukemia in 2006, mo...
Kaydedildi:
| Yayımlandı: | CNS Oncol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Future Medicine Ltd
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6166540/ https://ncbi.nlm.nih.gov/pubmed/25054580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.13.24 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|